Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
37.19
-1.01 (-2.64%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $4.04 billion as of October 16, 2026. It is the 4,144th most valuable company in the world and the 1,278th biggest in the United States. Its market cap has increased by 145.46% in one year.
Market Cap
4.04B
Enterprise Value
3.58B
1-Year Change
145.46%
Global Rank
Country Rank
#1,278 United States
Category
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $4.04B, an increase of 430.70%. That is a compound annual growth rate of 35.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 4.04B | 53.74% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.86B |
| Scholar Rock Holding | 4.82B |
| Veradermics | 4.74B |
| Definium Therapeutics | 4.60B |
| Dianthus Therapeutics | 4.18B |
| AbCellera Biologics | 4.01B |
| Tango Therapeutics | 3.74B |
| Relay Therapeutics | 3.74B |